0001883850-21-000009.txt : 20211119
0001883850-21-000009.hdr.sgml : 20211119
20211119175044
ACCESSION NUMBER: 0001883850-21-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211119
FILED AS OF DATE: 20211119
DATE AS OF CHANGE: 20211119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHLEIFER LEONARD S
CENTRAL INDEX KEY: 0001218629
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211429609
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-11-19
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001218629
SCHLEIFER LEONARD S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
President & CEO
Common Stock
2021-11-19
4
M
0
239063
270.43
A
543809
D
Common Stock
2021-11-19
4
F
0
173491
651.96
D
370318
D
Common Stock
2021-11-19
4
M
0
281250
179.13
A
651568
D
Common Stock
2021-11-19
4
F
0
185646
651.96
D
465922
D
Common Stock
200000
I
2021 GRAT
Common Stock
5874
I
By 401(k) Plan
Common Stock
21178
I
By Trust
Non-Qualified Stock Option (right to buy)
179.13
2021-11-19
4
M
0
281250
0.0
D
2022-12-14
Common Stock
281250
0
D
Non-Qualified Stock Option (right to buy)
270.43
2021-11-19
4
M
0
239063
0.0
D
2023-12-13
Common Stock
239063
0
D
These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Leonard S. Schleifer
2021-11-19